Prognostic significance of CXCL12 expression in patients with colorectal carcinoma

Yuri Akishima-Fukasawa, Yukihiro Nakanishi, Yoshinori Ino, Yoshihiro Moriya, Yae Kanai, Setsuo Hirohashi

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The present study investigated the protein expression level of CXCL12 in colorectal cancer and aimed to elucidate its association with prognosis. CXCL12 positivity in 50% or more of tumor cells was defined as high expression and that in less than 50% of the tumor cells as low expression. CXCL12+ tumor budding at the invasive front was divided into 2 grades: high with 10 or more budding foci per x200 field of view and low grade with fewer than 10 budding foci. Patients with high expression (72.7%) and high grade CXCL12+ tumor budding (43.0%) had significantly shorter survival than patients with low expression (P = .014) and low grade (P = .003), respectively. Patients with a combination of high expression and high grade had the worst outcome (P < .001). Our study demonstrated that CXCL12 expression in colorectal cancer cells and at sites of budding were significant prognostic factors. Furthermore, together with lymph node metastasis, a combination of both expression patterns was a more powerful independent prognostic factor.

Original languageEnglish
Pages (from-to)202-210
Number of pages9
JournalAmerican Journal of Clinical Pathology
Volume132
Issue number2
DOIs
Publication statusPublished - 2009 Aug
Externally publishedYes

Fingerprint

Colorectal Neoplasms
Neoplasms
Lymph Nodes
Neoplasm Metastasis
Survival
Proteins

Keywords

  • Colorectal carcinoma
  • CXCL12
  • Immunohistochemistry
  • Invasive front
  • Prognosis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Prognostic significance of CXCL12 expression in patients with colorectal carcinoma. / Akishima-Fukasawa, Yuri; Nakanishi, Yukihiro; Ino, Yoshinori; Moriya, Yoshihiro; Kanai, Yae; Hirohashi, Setsuo.

In: American Journal of Clinical Pathology, Vol. 132, No. 2, 08.2009, p. 202-210.

Research output: Contribution to journalArticle

Akishima-Fukasawa, Yuri ; Nakanishi, Yukihiro ; Ino, Yoshinori ; Moriya, Yoshihiro ; Kanai, Yae ; Hirohashi, Setsuo. / Prognostic significance of CXCL12 expression in patients with colorectal carcinoma. In: American Journal of Clinical Pathology. 2009 ; Vol. 132, No. 2. pp. 202-210.
@article{1c412e356d904104a4325961ead69c65,
title = "Prognostic significance of CXCL12 expression in patients with colorectal carcinoma",
abstract = "The present study investigated the protein expression level of CXCL12 in colorectal cancer and aimed to elucidate its association with prognosis. CXCL12 positivity in 50{\%} or more of tumor cells was defined as high expression and that in less than 50{\%} of the tumor cells as low expression. CXCL12+ tumor budding at the invasive front was divided into 2 grades: high with 10 or more budding foci per x200 field of view and low grade with fewer than 10 budding foci. Patients with high expression (72.7{\%}) and high grade CXCL12+ tumor budding (43.0{\%}) had significantly shorter survival than patients with low expression (P = .014) and low grade (P = .003), respectively. Patients with a combination of high expression and high grade had the worst outcome (P < .001). Our study demonstrated that CXCL12 expression in colorectal cancer cells and at sites of budding were significant prognostic factors. Furthermore, together with lymph node metastasis, a combination of both expression patterns was a more powerful independent prognostic factor.",
keywords = "Colorectal carcinoma, CXCL12, Immunohistochemistry, Invasive front, Prognosis",
author = "Yuri Akishima-Fukasawa and Yukihiro Nakanishi and Yoshinori Ino and Yoshihiro Moriya and Yae Kanai and Setsuo Hirohashi",
year = "2009",
month = "8",
doi = "10.1309/AJCPK35VZJEWCUTL",
language = "English",
volume = "132",
pages = "202--210",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "2",

}

TY - JOUR

T1 - Prognostic significance of CXCL12 expression in patients with colorectal carcinoma

AU - Akishima-Fukasawa, Yuri

AU - Nakanishi, Yukihiro

AU - Ino, Yoshinori

AU - Moriya, Yoshihiro

AU - Kanai, Yae

AU - Hirohashi, Setsuo

PY - 2009/8

Y1 - 2009/8

N2 - The present study investigated the protein expression level of CXCL12 in colorectal cancer and aimed to elucidate its association with prognosis. CXCL12 positivity in 50% or more of tumor cells was defined as high expression and that in less than 50% of the tumor cells as low expression. CXCL12+ tumor budding at the invasive front was divided into 2 grades: high with 10 or more budding foci per x200 field of view and low grade with fewer than 10 budding foci. Patients with high expression (72.7%) and high grade CXCL12+ tumor budding (43.0%) had significantly shorter survival than patients with low expression (P = .014) and low grade (P = .003), respectively. Patients with a combination of high expression and high grade had the worst outcome (P < .001). Our study demonstrated that CXCL12 expression in colorectal cancer cells and at sites of budding were significant prognostic factors. Furthermore, together with lymph node metastasis, a combination of both expression patterns was a more powerful independent prognostic factor.

AB - The present study investigated the protein expression level of CXCL12 in colorectal cancer and aimed to elucidate its association with prognosis. CXCL12 positivity in 50% or more of tumor cells was defined as high expression and that in less than 50% of the tumor cells as low expression. CXCL12+ tumor budding at the invasive front was divided into 2 grades: high with 10 or more budding foci per x200 field of view and low grade with fewer than 10 budding foci. Patients with high expression (72.7%) and high grade CXCL12+ tumor budding (43.0%) had significantly shorter survival than patients with low expression (P = .014) and low grade (P = .003), respectively. Patients with a combination of high expression and high grade had the worst outcome (P < .001). Our study demonstrated that CXCL12 expression in colorectal cancer cells and at sites of budding were significant prognostic factors. Furthermore, together with lymph node metastasis, a combination of both expression patterns was a more powerful independent prognostic factor.

KW - Colorectal carcinoma

KW - CXCL12

KW - Immunohistochemistry

KW - Invasive front

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=68549096319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68549096319&partnerID=8YFLogxK

U2 - 10.1309/AJCPK35VZJEWCUTL

DO - 10.1309/AJCPK35VZJEWCUTL

M3 - Article

VL - 132

SP - 202

EP - 210

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 2

ER -